About: Study of Avelumab and Cetuximab Plus Gemcitabine and Cisplatin in Participants With Squamous Non-small Cell Lung Cancer (NSCLC)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Study of Avelumab and Cetuximab Plus Gemcitabine and Cisplatin in Participants With Squamous Non-small Cell Lung Cancer (NSCLC) Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	Study of Avelumab and Cetuximab Plus Gemcitabine and Cisplatin in Participants With Squamous Non-small Cell Lung Cancer (NSCLC) (en)
skos:prefLabel	Study of Avelumab and Cetuximab Plus Gemcitabine and Cisplatin in Participants With Squamous Non-small Cell Lung Cancer (NSCLC) (en)
name	Study of Avelumab and Cetuximab Plus Gemcitabine and Cisplatin in Participants With Squamous Non-small Cell Lung Cancer (NSCLC) (en)
title	wds:Q62040624-2B824812-13D5-475C-90E7-D4979C19EE9B
title	A Phase IIa, Single-arm, Multicenter Study to Investigate the Clinical Activity and Safety of Avelumab in Combination With Cetuximab Plus Gemcitabine and Cisplatin in Participants With Advanced Squamous Non-small-cell Lung Cancer (en)
end time	wds:Q62040624-FC4707AD-9D63-47C6-AFAC-0FB541513745
end time	2021-01-25 00:00:00Z (xsd:dateTime)
instance of	wds:Q62040624-DE46A01D-7640-4B0D-8B98-DBD25135C613
instance of	clinical trial
start time	wds:Q62040624-AA1E861D-E6DD-47F3-80BE-35899A04FD05
start time	2018-10-30 00:00:00Z (xsd:dateTime)
country	wds:Q62040624-006FDE65-EB14-4E86-9297-9EC9411C2E0A wds:Q62040624-F4F92239-C9FC-4161-83BA-A2CC9C203DF8
country	Spain Hungary
main subject	wds:Q62040624-E1F1034C-9270-40DC-8EA7-4FB0D1F75C7F
main subject	non small cell lung cancer recurrent
research site	wds:Q62040624-1322BC89-A0CE-48ED-A115-99458F3498AE
research site	Hospital Universitario Virgen del Rocío
research intervention	wds:Q62040624-0F043AE3-17FE-488F-A964-F8CBFF6C95D7 wds:Q62040624-5293A50C-D00C-4B69-864A-29467D622DA2 wds:Q62040624-B8ED45BE-6FA4-4FA7-8A3C-A633F967C177
research intervention	cetuximab wd:Q414143 cisplatin
number of participants	wds:Q62040624-7540CE62-0C18-4339-BEA9-826973CE979F
number of participants	45 (xsd:decimal)
study type	wds:Q62040624-95D5D382-A5D2-4203-9292-41CE51B10A73
study type	interventional study
ClinicalTrials.gov ID	wds:Q62040624-15AE77A5-A993-475F-95E1-C739483034FA
ClinicalTrials.gov ID	NCT03717155
clinical trial phase	wds:Q62040624-741C665E-1894-4EFD-8592-8E76797E0BFF
clinical trial phase	phase II clinical trial
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q62040624

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software